Current recommendations: What is the clinician to do?

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages 916-921

  Manson, Joann E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

benefit risk profile; clinical decision making; Hormone therapy

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN; LIPID; MEDROXYPROGESTERONE ACETATE;

BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL DECISION MAKING; COGNITION; GROUPS BY AGE; HEART INFARCTION; HORMONAL THERAPY; HUMAN; MENOPAUSAL HORMONE THERAPY; MENOPAUSE; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION; TREATMENT INDICATION; VEIN THROMBOSIS;

BENEFIT-RISK PROFILE; CLINICAL DECISION MAKING; HORMONE THERAPY;

AGE FACTORS; DECISION MAKING; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 84897139108     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2014.02.043     Document Type: Review

References (23)

1. American College of Physicians Guidelines for counseling postmenopausal women about preventive hormone therapy Ann Intern Med 117 1992 1038 1041
2. D. Grady, S.M. Rubin, D.B. Petitti, C.S. Fox, D. Black, and B. Ettinger et al. Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016 1037
3. A.L. Hersh, M.L. Stefanick, and R.S. Stafford National use of postmenopausal hormone therapy: annual trends and response to recent evidence JAMA 291 2004 47 53
4. J.E. Manson, and S.S. Bassuk The menopause transition and postmenopausal hormone therapy D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jamison, J. Loscalzo, Harrison's principles of internal medicine 2011 McGraw-Hill New York
5. Women's Health Initiative Study Group Design of the Women's Health Initiative clinical trial and observational study Control Clin Trials 19 1998 61 109
6. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, and M.L. Stefanick et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 2002 321 333
7. G.L. Anderson, M. Limacher, A.R. Assaf, T. Bassford, S.A. Beresford, and H. Black et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 291 2004 1701 1712
8. J.E. Manson, R.T. Chlebowski, M.L. Stefanick, A.K. Aragaki, J.E. Rossouw, and R.L. Prentice et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials JAMA 310 2013 1353 1368
9. M.E. Mendelsohn, and R.H. Karas Molecular and cellular basis of cardiovascular gender differences Science 308 2005 1583 1587
10. North American Menopause Society Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society Menopause 17 2010 242 255
11. International Menopause Society Aging, menopause, cardiovascular disease and HRT. International Menopause Society consensus statement Climacteric 12 2009 368 377
12. R.J. Santen, D.C. Allred, S.P. Ardoin, D.F. Archer, N. Boyd, and G.D. Braunstein et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement J Clin Endocrinol Metab 95 7 Suppl 1 2010 s1 s66
13. T.S. Mikkola, and T.B. Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res 53 2002 605 619
14. P.F. Bray, J.C. Larson, A.Z. Lacroix, J. Manson, M.C. Limacher, and J.E. Rossouw et al. Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events Am J Cardiol 101 2008 1599 1605
15. R.A. Wild, C. Wu, J.D. Curb, L.W. Martin, L. Phillips, and M. Stefanick et al. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials Menopause 20 2013 254 260
16. J.E. Manson The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy Metabolism 62 Suppl 1 2013 S15 S19
17. S.S. Bassuk, and J.E. Manson Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification Clin Chem 60 2014 68 77
18. S.A. Shumaker, C. Legault, S.R. Rapp, L. Thal, R.B. Wallace, and J.K. Ockene et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial JAMA 289 2003 2651 2662
19. M.A. Espeland, S.A. Shumaker, I. Leng, J.E. Manson, C.M. Brown, and E.S. Leblanc et al. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years JAMA Intern Med 173 2013 1429 1436
20. North American Menopause Society The 2012 hormone therapy position statement of the North American Menopause Society Menopause 19 2012 257 271
21. R.B. d'Agostino, P.A. Wolf, A.J. Belanger, and W.B. Kannel Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study Stroke 25 1994 40 43
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 2001 2486 2497
23. N.J. Stone, J. Robinson, A.H. Lichtenstein, C.N. Merz, C.B. Blum, and R.H. Eckel et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 2013 Nov 12 [Epub ahead of print]